Log In
Print
BCIQ
Print
Print this Print this
 

Epodure (MDGN-201)

  Manage Alerts
Collapse Summary General Information
Company Medgenics Inc.
DescriptionTransdermal biopump implant device that produces erythropoietin (EPO)
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentPhase II
Standard IndicationAnemia
Indication DetailsTreat anemia in chronic kidney disease (CKD) patients; Treat anemia in dialysis patients; Treat anemia in end-stage renal disease (ESRD) and chronic kidney disease (CKD) patients; Treat anemia in patients with end-stage renal disease (ESRD)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today